HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Comparative evaluation of megadose methylprednisolone with dexamethasone for treatment of primary typical optic neuritis.

AbstractAIM:
To compare the efficacy of intravenous methylprednisolone and intravenous dexamethasone on visual recovery and evaluate their side-effects for the treatment of optic neuritis.
MATERIALS AND METHODS:
Prospective, randomized case-controlled study including 21 patients of acute optic neuritis presenting within eight days of onset and with visual acuity less then 20/60 in the affected eye who were randomly divided into two groups. Group I received intravenous dexamethasone 200 mg once daily for three days and Group II received intravenous methylprednisolone 250 mg/six-hourly for three days followed by oral prednisolone for 11 days. Parameters tested were pupillary reactions, visual acuity, fundus findings, color vision, contrast sensitivity, Goldmann visual fields and biochemical investigations for all patients at presentation and follow-up.
RESULTS:
Both groups were age and sex-matched. LOGMAR visual acuity at presentation was 1.10 +/- 0.52 in Group I and 1.52 +/- 0.43 in Group II. On day 90 of steroid therapy, visual acuity improved to 0.28 +/- 0.33 in Group I and 0.36 +/- 0.41 in Group II ( P =0.59). At three months there was no statistically significant difference in the color vision, contrast sensitivity, stereoacuity, Goldman fields and the amplitude and latency of visually evoked response between the two groups. The concentration of vitamin C, glucose, sodium, potassium, urea and creatinine were within the reported normal limits.
CONCLUSION:
Intravenous dexamethasone is an effective treatment for optic neuritis. However, larger studies are required to establish it as a safe, inexpensive and effective modality for the treatment of optic neuritis.
AuthorsVimala Menon, Abhas Mehrotra, Rohit Saxena, Nargis F Jaffery
JournalIndian journal of ophthalmology (Indian J Ophthalmol) 2007 Sep-Oct Vol. 55 Issue 5 Pg. 355-9 ISSN: 0301-4738 [Print] India
PMID17699944 (Publication Type: Comparative Study, Journal Article, Randomized Controlled Trial)
Chemical References
  • Glucocorticoids
  • Neuroprotective Agents
  • Dexamethasone
  • Methylprednisolone
Topics
  • Adolescent
  • Adult
  • Case-Control Studies
  • Child
  • Color Perception (physiology)
  • Dexamethasone (administration & dosage)
  • Dose-Response Relationship, Drug
  • Drug Therapy, Combination
  • Female
  • Follow-Up Studies
  • Glucocorticoids (administration & dosage)
  • Humans
  • Injections, Intravenous
  • Male
  • Methylprednisolone (administration & dosage)
  • Middle Aged
  • Neuroprotective Agents (administration & dosage)
  • Ophthalmoscopy
  • Optic Neuritis (drug therapy, pathology, physiopathology)
  • Prospective Studies
  • Recovery of Function
  • Treatment Outcome
  • Vision, Binocular (physiology)
  • Visual Acuity (physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: